MAYINGLONG HEMORRHOIDS OINTMENT

Manufacturer
Mayinglong Pharmaceutical Group Co Ltd
Effective date
2019-08-19
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:00:05

Label at a glance#

ProductMAYINGLONG HEMORRHOIDS
Active ingredientZINC OXIDE, PETROLATUM
Label structure11 sections

Indications and uses

helps relieve the local itching and discomfort associated with hemorrhoids temporarily shrinks hemorrhoidal tissue and relieves burning temporarily provides a coating for relief of anorectal discomforts temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Zinc Oxide 0.8g Astrigent

Petrolatum 7.85g Protectant

Purpose

OTC - PURPOSE SECTION

Astrigent

Protectant

Protectant

Uses

INDICATIONS & USAGE SECTION

helps relieve the local itching and discomfort associated with hemorrhoids

temporarily shrinks hemorrhoidal tissue and relieves burning

temporarily provides a coating for relief of anorectal discomforts

temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Warning

WARNINGS SECTION

For external and /or intrarectal use only. Not for oral use.

Stop use

OTC - STOP USE SECTION

bleeding occurs

condition worses or does not improve within 7 days

introduction of applicator into the rectum causes additional pain

Warning

PREGNANCY SECTION

Apply it carfully during pregnancy.

Warning

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all drugs out of reach of children.

Direction

DOSAGE & ADMINISTRATION SECTION

Apply properly onto anus or apply on affected areas twice a day.

Other information

OTHER SAFETY INFORMATION

Store at 20-25 degree Centigrade (68-77 degree Fahrenheit)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Musk Ketone

Pearl (Hyriopsis Cumming II)

Borneol

Sodium Borate

Drug Facts

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

mayinglong box18mayinglong box18

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2058531petrolatum 78.5 % / zinc oxide 8 % Topical OintmentPSN2
2058531petrolatum 0.785 MG/MG / zinc oxide 0.08 MG/MG Topical OintmentSCD2
2058531Petrolatum 0.785 MG/MG / ZNO 0.08 MG/MG Topical OintmentSY2
2058531petrolatum 78.5 % / zinc oxide 8 % Topical OintmentSY2

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68511-993-02MAYINGLONG HEMORRHOIDS10000 mg in 1 CARTONOINTMENT100002
68511-993-03MAYINGLONG HEMORRHOIDS4000 mg in 1 CARTONOINTMENT40002
68511-993-04MAYINGLONG HEMORRHOIDS20000 mg in 1 CARTONOINTMENT200002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68511-993MAYINGLONG HEMORRHOIDS (ZINC OXIDE, PETROLATUM, LANOLIN) OINTMENT [MAYINGLONG PHARMACEUTICAL GROUP CO LTD]2Legacy NDC, 3 package rows20190820_83f95bd2-f297-37c9-e053-2a91aa0a96ea.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68511-993-01GM - Gram68511-9931b609418-fdeb-4dac-8f33-f790be1e0ef612022-06-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68511-99368511-993-02, 68511-993-03, 68511-993-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
907e01f8-0307-5d46-e053-2a95a90adcb883f95bd2-f297-37c9-e053-2a91aa0a96ea2019-08-19WarningsExact identifier
spl id: 907e01f8-0307-5d46-e053-2a95a90adcb8
spl set id: 83f95bd2-f297-37c9-e053-2a91aa0a96ea

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.